Indeed, together with c-Myc, Hif-1α is known to simultaneously induce glycolytic genes and inhibitors of mitochondrial metabolism [60, 71–73], to reduce mitochondrial biogenesis [74, 75] and to play a key role in metabolic reprogramming in many tumour types [69, 72, 74–76]. This evidence concerns the gene HIF1A and neoplasm.